AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9661646 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (2 mg/day for 4 days)
Number of subjects: 117
Study 9661646 — intervention group
Group type: EXPERIMENTAL
Intervention: Long PCR technique
Number of subjects: 117
Study 9661646 — intervention group
Group type: EXPERIMENTAL
Intervention: Short term dexamethasone suppression test
Number of subjects: 117
Study 8917929 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult suggestions
Number of subjects: 78
Study 8917929 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy suggestions
Number of subjects: 78
Study 8917929 — intervention group
Group type: EXPERIMENTAL
Intervention: Posthypnotic suggestion
Number of subjects: 78
Study 2643423 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% fat treatment diet (9% saturated fat, 15% polyunsaturated fat, 14% monounsaturated fat, 166 mg dietary cholesterol per day)
Number of subjects: 9057
Study 2643423 — intervention group
Group type: COMPARATOR
Intervention: 39% fat control diet (18% saturated fat, 5% polyunsaturated fat, 16% monounsaturated fat, 446 mg dietary cholesterol per day)
Number of subjects: 9057
Study 2643423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and control diets
Number of subjects: 9057
Study 1095962 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg SAMe i.v. or i.m. administered four times a day for 30 days
Number of subjects: 15
Study 1095962 — intervention group
Group type: COMPARATOR
Intervention: Equimolecular doses of L-methionine and ATP
Number of subjects: 15
Study 30455321 — intervention group
Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus background therapy of mycophenolate and steroids
Number of subjects: 0
Study 30455321 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus background therapy of mycophenolate and steroids
Number of subjects: 0
Study 28499272 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone
Number of subjects: 118
Study 28499272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 25749542 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy plus famciclovir (antiviral treatment)
Number of subjects: 0
Study 25749542 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (control group)
Number of subjects: 0
Study 23429062 — intervention group
Group type: COMPARATOR
Intervention: Higher body mass index and less likely to report estrogen or aspirin use
Number of subjects: 37459
Study 23429062 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 37459
Study 23429062 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous hysterectomy
Number of subjects: 37459
Study 23429062 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 37459
Study 21447772 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 40
Study 21447772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 19547811 — intervention group
Group type: EXPERIMENTAL
Intervention: bromazepam 3 mg
Number of subjects: 45
Study 19547811 — intervention group
Group type: EXPERIMENTAL
Intervention: bromazepam 6 mg
Number of subjects: 45
Study 19547811 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study 16297442 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription-based counseling and self-monitoring (MON)
Number of subjects: 265
Study 16297442 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring (MON)
Number of subjects: 265
Study 16297442 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 265
Study 15611808 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium and fluticasone/salmeterol
Number of subjects: 432
Study 15611808 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium and salmeterol
Number of subjects: 432
Study 15611808 — intervention group
Group type: COMPARATOR
Intervention: tiotropium and placebo inhaler
Number of subjects: 432
Study 15611808 — intervention group
Group type: EXPERIMENTAL
Intervention: not specified
Number of subjects: 432
Study 11414874 — intervention group
Group type: EXPERIMENTAL
Intervention: naltrexone hydrochloride (1.5 mg/kg/day)
Number of subjects: 4
Study 11414874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 9241008 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day on days 8-17 followed by 30 mg/day on days 18-20)
Number of subjects: 24
Study 9241008 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (50 mg/day on days 8-17 and 100 mg/day on days 18-20)
Number of subjects: 24
Study 8098758 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0
Study 8098758 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 0
Study 8098758 — intervention group
Group type: EXPERIMENTAL
Intervention: Idazoxan
Number of subjects: 0
Study 8098758 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 0
Study 8098758 — intervention group
Group type: EXPERIMENTAL
Intervention: ST-91
Number of subjects: 0
Study 8098758 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (epidural administration in human volunteers)
Number of subjects: 0
Study 3122189 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 71
Study 3122189 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 71
Study 31228563 — intervention group
Group type: EXPERIMENTAL
Intervention: Models adjusted for important baseline confounders
Number of subjects: 0
Study 31228563 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher outcome intraclass correlation coefficients
Number of subjects: 0
Study 29778971 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraclavicular block with ropivacaine
Number of subjects: 150
Study 29778971 — intervention group
Group type: EXPERIMENTAL
Intervention: Infraclavicular block with ropivacaine
Number of subjects: 150
Study 27692498 — intervention group
Group type: EXPERIMENTAL
Intervention: ixekizumab
Number of subjects: 0
Study 27692498 — intervention group
Group type: COMPARATOR
Intervention: etanercept
Number of subjects: 0
Study 27692498 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 24752165 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (SUG group)
Number of subjects: 88
Study 24752165 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine (NEO group)
Number of subjects: 88
Study 22333855 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia learning tool (MMLT)
Number of subjects: 25
Study 22333855 — intervention group
Group type: COMPARATOR
Intervention: Textbook excerpt
Number of subjects: 25
Study 21044535 — intervention group
Group type: EXPERIMENTAL
Intervention: Project-based intervention using the PREDEA curriculum, 30 minutes daily from mid December to mid June.
Number of subjects: 1123
Study 21044535 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving available remedial services at their schools.
Number of subjects: 1123
Study 18415758 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-l sulphate-free polyethylene glycol solution (SF-PEG)
Number of subjects: 110
Study 18415758 — intervention group
Group type: COMPARATOR
Intervention: 4-l polyethylene glycol solution (PEG)
Number of subjects: 110
Study 16206502 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten pretreated with prolyl endopeptidase (PEP)
Number of subjects: 20
Study 16206502 — intervention group
Group type: COMPARATOR
Intervention: Gluten not treated with PEP
Number of subjects: 20
Study 11839625 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine analogue [123I]m‐iodobenzylguanidine (123I‐MIBG) SPECT
Number of subjects: 17
Study 10369627 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolide therapy (azithromycin or roxithromycin)
Number of subjects: 0
Study 10369627 — intervention group
Group type: COMPARATOR
Intervention: Chlamydia pneumoniae infection
Number of subjects: 0
Study 7772935 — intervention group
Group type: EXPERIMENTAL
Intervention: 75-g oral glucose tolerance test
Number of subjects: 32
Study 7772935 — intervention group
Group type: COMPARATOR
Intervention: 100-g oral glucose tolerance test
Number of subjects: 32
Study 2181138 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure using elasticated bands with a plastic button at the P6 point
Number of subjects: 162
Study 2181138 — intervention group
Group type: COMPARATOR
Intervention: Control dummy bands without the pressure button
Number of subjects: 162
Study 2181138 — intervention group
Group type: COMPARATOR
Intervention: Antiemetic injections of prochlorperazine
Number of subjects: 162
Study 834983 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (400 mg/day)
Number of subjects: 35
Study 834983 — intervention group
Group type: COMPARATOR
Intervention: Mefruside (mean maximal dose 110 mg/day)
Number of subjects: 35
Study 31221693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - 10 sessions over 12 weeks
Number of subjects: 140
Study 31221693 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based exercise (EXER) - 12 weeks including six sessions with a personal trainer
Number of subjects: 140
Study 31221693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy + Community-based exercise (CBT+EXER) - concurrent over a 12-week period
Number of subjects: 140
Study 31221693 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 140
Study 28082261 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel coils
Number of subjects: 447
Study 28082261 — intervention group
Group type: COMPARATOR
Intervention: Bare platinum coils
Number of subjects: 447
Study 24622577 — intervention group
Group type: COMPARATOR
Intervention: Cold-water immersion (CWI)
Number of subjects: 30
Study 24622577 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 30
Study 24622577 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study 22784417 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridge preservation with corticocancellous porcine bone and a collagen membrane
Number of subjects: 0
Study 22784417 — intervention group
Group type: COMPARATOR
Intervention: Control group with silk sutures and no grafting material
Number of subjects: 0
Study 21701378 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-jaw group
Number of subjects: 20
Study 21701378 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-jaw group
Number of subjects: 20
Study 18716392 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-help program (2 weeks duration)
Number of subjects: 43
Study 17063135 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-component model (3CM) intervention
Number of subjects: 224
Study 14513925 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 10
Study 14513925 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 10
Study 14513925 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 mg)
Number of subjects: 10
Study 14513925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11210856 — intervention group
Group type: EXPERIMENTAL
Intervention: P&B 2.1
Number of subjects: 80
Study 11210856 — intervention group
Group type: EXPERIMENTAL
Intervention: P&B 2.1/NaOCl
Number of subjects: 80
Study 11210856 — intervention group
Group type: EXPERIMENTAL
Intervention: SB
Number of subjects: 80
Study 11210856 — intervention group
Group type: EXPERIMENTAL
Intervention: SB/NaOCl
Number of subjects: 80
Study 9170478 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring with a meter
Number of subjects: 342
Study 9170478 — intervention group
Group type: COMPARATOR
Intervention: Clinic follow-up
Number of subjects: 342
Study 9170478 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast test cutoff of 7.8 mmol/L
Number of subjects: 342
Study 1554179 — intervention group
Group type: COMPARATOR
Intervention: 5 mg haloperidol IM
Number of subjects: 68
Study 1554179 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg droperidol IM
Number of subjects: 68
Study 1554179 — intervention group
Group type: COMPARATOR
Intervention: haloperidol IV
Number of subjects: 68
Study 1554179 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg droperidol IV
Number of subjects: 68
Study 4033866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (1.4 ml 100 proof vodka/kg body weight)
Number of subjects: 31
Study 4033866 — intervention group
Group type: COMPARATOR
Intervention: Control (0 ml vodka)
Number of subjects: 31
Study 30936687 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 164
Study 30936687 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 164
Study 30456520 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron Isomaltoside (IIM)
Number of subjects: 0
Study 30456520 — intervention group
Group type: COMPARATOR
Intervention: Ferric Carboxymaltose (FCM)
Number of subjects: 0
Study 27110446 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based prevention program (intervention)
Number of subjects: 191
Study 27110446 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 191
Study 22515728 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% zinc pyrithione (ZPT) shampoo
Number of subjects: 0
Study 22515728 — intervention group
Group type: COMPARATOR
Intervention: Placebo cosmetic shampoo
Number of subjects: 0
Study 22709609 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief alcohol intervention (WDYD)
Number of subjects: 750
Study 22709609 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 750
Study 20579404 — intervention group
Group type: EXPERIMENTAL
Intervention: High-total antioxidant capacity (HT) diet
Number of subjects: 19
Study 20579404 — intervention group
Group type: COMPARATOR
Intervention: Low-total antioxidant capacity (LT) diet
Number of subjects: 19
Study 16520435 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine (50 mg)
Number of subjects: 27
Study 16520435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 14652120 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 26
Study 14652120 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 26
Study 10646124 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 60
Study 10646124 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate
Number of subjects: 60
Study 10646124 — intervention group
Group type: COMPARATOR
Intervention: Clodronate
Number of subjects: 60
Study 9296406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (0.1 mg/kg to 4 mg intravenously)
Number of subjects: 429
Study 9296406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study 8445378 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral group therapy (N = 30)
Number of subjects: 93
Study 8445378 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual behavior therapy (N = 31)
Number of subjects: 93
Study 8445378 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (Control group, N = 32)
Number of subjects: 93
Study 3296296 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily beclomethasone dipropionate (500 micrograms/day)
Number of subjects: 21
Study 3296296 — intervention group
Group type: COMPARATOR
Intervention: Four times daily standard dose inhaler (400 micrograms/day)
Number of subjects: 21
Study 30815880 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 27
Study 30815880 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV)
Number of subjects: 27
Study 28930879 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration protocol (DHY: 3‐hour cycling at 60 W in 40° C to induce 5% dehydration)
Number of subjects: 14
Study 28930879 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration protocol (DHY)
Number of subjects: 14
Study 28930879 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral control (CONT)
Number of subjects: 14
Study 26681403 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg/kg, intraperitoneally) in rats
Number of subjects: 95
Study 26681403 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg/day, orally) in humans
Number of subjects: 95
Study 26681403 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo (control group) in humans
Number of subjects: 95
Study 24983706 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined AIT and strength training (COM)
Number of subjects: 42
Study 24983706 — intervention group
Group type: COMPARATOR
Intervention: High-intensity aerobic interval training (AIT)
Number of subjects: 42
Study 22968523 — intervention group
Group type: EXPERIMENTAL
Intervention: ferumoxytol 1 g
Number of subjects: 15
Study 20935398 — intervention group
Group type: EXPERIMENTAL
Intervention: AScVS (anti-scorpion venom serum) administered as an intravenous slow bolus, ranging from 40 to 100 ml depending on severity
Number of subjects: 81
Study 20935398 — intervention group
Group type: COMPARATOR
Intervention: Prazosin given as 1 mg every 3 h
Number of subjects: 81
Study 20935398 — intervention group
Group type: EXPERIMENTAL
Intervention: AScVS + prazosin
Number of subjects: 81
Study 18802155 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg once weekly
Number of subjects: 112
Study 18802155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 18802155 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate initiated in year 2
Number of subjects: 112
Study 18802155 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate for 2 years
Number of subjects: 112
Study 17257724 — intervention group
Group type: EXPERIMENTAL
Intervention: IMB intervention (Information‐Motivation‐Behavioral Skills model)
Number of subjects: 250
Study 17257724 — intervention group
Group type: COMPARATOR
Intervention: Information‐only control condition
Number of subjects: 250
Study 14499232 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 8 weeks in treated subjects
Number of subjects: 22
Study 14499232 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 8 weeks in untreated subjects
Number of subjects: 22
Study 14499232 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 22
Study 14499232 — intervention group
Group type: COMPARATOR
Intervention: Control group (treated subjects)
Number of subjects: 22
Study 10707914 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous physical exertion
Number of subjects: 699
Study 10707914 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary subjects
Number of subjects: 699
Study 10707914 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status
Number of subjects: 699
Study 10707914 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (case-crossover analysis)
Number of subjects: 699
Study 9088805 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 90
Study 9088805 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 90
Study 9088805 — intervention group
Group type: COMPARATOR
Intervention: Lithium and Carbamazepine
Number of subjects: 90
Study 8450893 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline oxide (AO) 60-90 mg
Number of subjects: 197
Study 8450893 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (AM) 50-75 mg
Number of subjects: 197
Study 8450893 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 197
Study 2876658 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot) given twice daily
Number of subjects: 18
Study 2876658 — intervention group
Group type: COMPARATOR
Intervention: Ordinary oral beta 2-agonist treatment given three times daily
Number of subjects: 18
Study 2876658 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot)
Number of subjects: 18
Study 31464643 — intervention group
Group type: EXPERIMENTAL
Intervention: Bikram yoga
Number of subjects: 34
Study 31464643 — intervention group
Group type: COMPARATOR
Intervention: HIIT
Number of subjects: 34
Study 28028288 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-debriefing
Number of subjects: 50
Study 28028288 — intervention group
Group type: COMPARATOR
Intervention: Instructor debriefing
Number of subjects: 50
Study 26271141 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab (GLM) 50 mg every 4 weeks for 48 weeks
Number of subjects: 30
Study 26271141 — intervention group
Group type: COMPARATOR
Intervention: Pamidronate (PAM) 60 mg every 4 weeks for 48 weeks
Number of subjects: 30
Study 26271141 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab (GLM)
Number of subjects: 30
Study 26271141 — intervention group
Group type: COMPARATOR
Intervention: Pamidronate (PAM)
Number of subjects: 30
Study 26271141 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab (GLM) and Pamidronate (PAM)
Number of subjects: 30
Study 23889690 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arm (specific intervention details not provided)
Number of subjects: 631
Study 23889690 — intervention group
Group type: COMPARATOR
Intervention: Control group (specific control details not provided)
Number of subjects: 631
Study 22103234 — intervention group
Group type: EXPERIMENTAL
Intervention: In-group robot
Number of subjects: 0
Study 22103234 — intervention group
Group type: COMPARATOR
Intervention: Out-group robot
Number of subjects: 0
Study 19207416 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training with slow movement and tonic force generation (LST) - approximately 55-60% one repetition maximum (1RM) load, 3 s lifting and 3 s lowering with no relaxation phase, n = 12
Number of subjects: 36
Study 19207416 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training at normal speed (HN) - approximately 85-90% 1RM, 1 s lifting and 1 s lowering with 1 s relaxation, n = 12
Number of subjects: 36
Study 19207416 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control (CON), n = 12
Number of subjects: 36